[A "new" look at "old" borreliosis].
The threat of borreliosis is a growing medical problem. The number of cases is constantly increasing, and the diagnostic methods and recommended treatment methods do not bring new values in comparison to the findings from over 30 years ago. Among the pathogens transmitted by ticks, apart from Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia species, Neoehrlichia mikurensis, as well as fever caused by rickettsiae and others, are referred to as "emerging" or "rediscovered". Recently published new recommendations for the diagnosis and treatment of Lyme disease developed by specialists from the National Institute for Health and Care Excellence (NICE) in the United Kingdom did not bring significant changes to the existing recommendations for the diagnosis and treatment of patients with borreliosis. This study does not provide information about vaccine research, which, it turned out, was introduced in the 1990s and withdrawn from the market. Research is currently under wal into an anti-tick "vaccine" undertaken by the team under the EU project "ANTIDOTE" (Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe). The first effects of the research are already presented, but we still have to wait for the final product.